Skip to content

Prognostic Importance of Physical Activity in Geriatric Patients With Acute Coronary Syndrome

Prognostic Importance of Physical Activity Level in Geriatric Patients With Acute Coronary Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07203924
Enrollment
207
Registered
2025-10-02
Start date
2024-12-04
Completion date
2025-09-11
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes, Geriatric Patients, Physical Activity Levels

Keywords

Acute Coronary Syndrome, TIMI, HEART, SVEAT, Physical Activity

Brief summary

This observational study evaluated the relationship between physical activity level and prognosis in geriatric patients admitted to the emergency department with acute coronary syndrome (ACS). A total of 207 patients aged 65 years and older were included. Physical activity level was assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF) and compared with clinical outcomes and risk scores (TIMI, HEART, SVEAT). Results showed that patients with higher physical activity levels had lower rates of major adverse cardiac events (MACE) and mortality, as well as lower risk scores. The findings suggest that physical activity is an independent protective factor that improves prognosis in older patients with ACS.

Detailed description

Acute coronary syndrome (ACS) in elderly patients is associated with high morbidity and mortality, and identifying prognostic factors is clinically important. Physical activity is known to have protective cardiovascular effects, but its prognostic role in geriatric ACS patients remains unclear. This observational study will include 207 patients aged 65 years and older who present to the emergency department with ACS. Physical activity levels will be measured using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). Activity scores will then be compared with clinical outcomes, including major adverse cardiac events (MACE), mortality, and risk stratification scores (TIMI, HEART, SVEAT).

Interventions

None listed

Sponsors

Balikesir University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 65 years * Admission to the emergency department with a diagnosis of acute coronary syndrome (ACS) * Ability to complete the International Physical Activity Questionnaire-Short Form (IPAQ-SF)

Exclusion criteria

* Age \< 65 years * Patients without ACS diagnosis * Patients unable to complete the IPAQ-SF questionnaire (e.g., due to severe cognitive impairment or communication problems)

Design outcomes

Primary

MeasureTime frameDescription
Major Adverse Cardiac Events (MACE)Within 30 days after emergency department admissionOccurrence of major adverse cardiac events (MACE) including STEMI, NSTEMI, unstable angina, or cardiovascular mortality.

Secondary

MeasureTime frameDescription
Physical Activity Score (IPAQ-SF)At baseline (hospital admission, emergency department evaluation)Physical activity level measured using the International Physical Activity Questionnaire Short Form (IPAQ-SF). Score range: 0 to 1920 MET-minutes/week. Higher scores indicate greater levels of physical activity.
TIMI Risk ScoreAt baseline (emergency department evaluation)Thrombolysis in Myocardial Infarction (TIMI) Risk Score. Risk stratification assessed using the TIMI Risk Score, which is based on clinical history, electrocardiogram findings, troponin levels, and cardiovascular risk factors. Score range: 0 to 7. Higher scores indicate greater risk and worse prognosis.
HEART Risk ScoreAt baseline (emergency department evaluation)HEART Risk Score (History, Electrocardiogram, Age, Risk factors, Troponin). Risk stratification assessed using the HEART Risk Score, which is based on patient history, electrocardiogram findings, age, cardiovascular risk factors, and troponin levels. Score range: 0 to 10. Higher scores indicate increased risk of major adverse cardiac events (worse prognosis).
SVEAT Risk ScoreAt baseline (emergency department evaluation)SVEAT Risk Score (Symptoms, Vascular disease, Electrocardiogram, Age, Troponin). Risk stratification assessed using the SVEAT Risk Score, based on symptoms, history of vascular disease, electrocardiogram findings, age, and troponin levels. Score range: 0 to 10. Higher scores indicate increased cardiovascular risk and worse prognosis.
All-cause MortalityWithin 30 days after admissionDeath from any cause among study participants after acute coronary syndrome.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026